|
|
 Previous Article | Table of Contents | Next Article 
Increased Recruitment of Hematopoietic Progenitor Cells Underlies the Ex Vivo Expansion Potential of FLT3 Ligand
David N. Haylock,
Martyn J. Horsfall,
Tracey L. Dowse,
Hayley S. Ramshaw,
Silvana Niutta,
Sandra Protopsaltis,
Li Peng,
Christopher Burrell,
Irene Rappold,
Hans-Jorg Buhring, and
Paul J. Simmons
From the Matthew Roberts Laboratory, Haematology Division, and Division of Infectious Disease, Institute of Medical and Veterinary Science, Adelaide, South Australia; and the University of Tübingen, Tübingen, Germany.
The ligand for flt-3 (FLT3L) exhibits striking structural homology with stem cell factor (SCF ) and monocyte colony-stimulating factor (M-CSF ) and also acts in synergy with a range of other hematopoietic growth factors (HGF ). In this study, we show that FLT3L responsive hematopoietic progenitor cells (HPC) are CD34+CD38-, rhodamine 123dull, and hydroperoxycyclophosphamide (4-HC) resistant. To investigate the basis for the capacity of FLT3L to augment the de novo generation of myeloid progenitors from CD34+CD38- cells, single bone marrow CD34+CD38- cells were sorted into Terasaki wells containing serum-free medium supplemented with interleukin-3 (IL-3), IL-6, granulocyte colony-stimulating factor (G-CSF ), SCF (4 HGF ) ± FLT3L. Under these conditions, FLT3L recruited approximately twofold more CD34+CD38- cells into division than 4 HGF alone. The enhanced proliferative response to FLT3L was evident by day 3 and was maintained at all subsequent time points examined. In accord with these findings, we also show that transduction of CD34+CD38- cells with the LAPSN retrovirus is enhanced by FLT3L. The results of these experiments therefore indicate that increased recruitment of primitive HPC into cell cycle underlies the ex vivo expansion potential of FLT3L and also its ability to improve retroviral transduction of HPC.
Blood, Vol. 90 No. 6 (September 15), 1997:
pp. 2260-2272
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
V. J. Jokubaitis, L. Sinka, R. Driessen, G. Whitty, D. N. Haylock, I. Bertoncello, I. Smith, B. Peault, M. Tavian, and P. J. Simmons
Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues
Blood,
April 15, 2008;
111(8):
4055 - 4063.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X.-L. Liu, J.-Y. Yuan, J.-W. Zhang, X.-H. Zhang, and R.-X. Wang
Differential gene expression in human hematopoietic stem cells specified toward erythroid, megakaryocytic, and granulocytic lineage
J. Leukoc. Biol.,
October 1, 2007;
82(4):
986 - 1002.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. G. Winkler, K. R. Snapp, P. J. Simmons, and J.-P. Levesque
Adhesion to E-selectin promotes growth inhibition and apoptosis of human and murine hematopoietic progenitor cells independent of PSGL-1
Blood,
March 1, 2004;
103(5):
1685 - 1692.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sergejeva, A.-K. Johansson, C. Malmhall, and J. Lotvall
Allergen exposure-induced differences in CD34+ cell phenotype: relationship to eosinophilopoietic responses in different compartments
Blood,
February 15, 2004;
103(4):
1270 - 1277.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Zheng, M. Levis, O. Piloto, P. Brown, B. R. Baldwin, N. C. Gorin, M. Beran, Z. Zhu, D. Ludwig, D. Hicklin, et al.
FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells
Blood,
January 1, 2004;
103(1):
267 - 274.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Christensen and I. L. Weissman
Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells
PNAS,
November 20, 2001;
(2001)
261562798.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. H. Cowan, J. A. Moscow, H. Huang, J. A. Zujewski, J. O'Shaughnessy, B. Sorrentino, K. Hines, C. Carter, E. Schneider, G. Cusack, et al.
Paclitaxel Chemotherapy after Autologous Stem-Cell Transplantation and Engraftment of Hematopoietic Cells Transduced with a Retrovirus Containing the Multidrug Resistance Complementary DNA (MDR1) in Metastatic Breast Cancer Patients
Clin. Cancer Res.,
July 1, 1999;
5(7):
1619 - 1628.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Goff, D. S. Shields, and J. S. Greenberger
Influence of Cytokines on the Growth Kinetics and Immunophenotype of Daughter Cells Resulting From the First Division of Single CD34+Thy-1+lin- Cells
Blood,
December 1, 1998;
92(11):
4098 - 4107.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Yu, T. A. Fehniger, P. Fuchshuber, K. S. Thiel, E. Vivier, W. E. Carson, and M. A. Caligiuri
Flt3 Ligand Promotes the Generation of a Distinct CD34+ Human Natural Killer Cell Progenitor That Responds to Interleukin-15
Blood,
November 15, 1998;
92(10):
3647 - 3657.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Schilz, G. Brouns, O. G. Ottmann, D. Hoelzer, A. A. Fauser, A. J. Thrasher, and M. Grez
High Efficiency Gene Transfer to Human Hematopoietic SCID-Repopulating Cells Under Serum-Free Conditions
Blood,
November 1, 1998;
92(9):
3163 - 3171.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.F. Tisdale, Y. Hanazono, S.E. Sellers, B.A. Agricola, M.E. Metzger, R.E. Donahue, and C.E. Dunbar
Ex Vivo Expansion of Genetically Marked Rhesus Peripheral Blood Progenitor Cells Results in Diminished Long-Term Repopulating Ability
Blood,
August 15, 1998;
92(4):
1131 - 1141.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Li, P. J. Simmons, and P. Kaur
Identification and isolation of candidate human keratinocyte stem cells based on cell surface phenotype
PNAS,
March 31, 1998;
95(7):
3902 - 3907.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Christensen and I. L. Weissman
Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells
PNAS,
December 4, 2001;
98(25):
14541 - 14546.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
